WJ-UC-MSCs to prevent Neuroinflammation after traumatic brain injury
Scale or prepare manufacturing, process control, GMP readiness and quality workflows.
Offer overview
What this offer helps you achieve
Scale or prepare manufacturing, process control, GMP readiness and quality workflows.
Scientific and technical scope
Mesenchymal stromal cells derived from Wharton’s Jelly of the umbilical cord, as immunomodulators of post-traumatic neuro-inflammation, developed by Stéphanie Sigaut & Vincent Degos Stage : Phase II Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury. (TRAUMACELL)- NCT06146062 - publication DOI: 10.1136/bmjopen-2024-091441
Capabilities mobilised
Therapeutic areasTherapeutic target discoveryBioproduction
Application fields
Neurology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
